Literature DB >> 15932322

Rapid synthetic route toward structurally modified derivatives of cyclic adenosine 5'-diphosphate ribose.

Gerd K Wagner1, Andreas H Guse, Barry V L Potter.   

Abstract

A concise synthesis of five new analogues of the second messenger cADPR (cyclic adenosine 5'-diphosphate ribose) is presented. The synthetic plan centered around the key derivative 8-Br-N1-cIDPR (cyclic 8-Br-inosine 5'-diphosphate ribose, 2), which was prepared in only three steps from IMP (inosine 5'-monophosphate) via an unusual enzymatic cyclization reaction. The enhanced stability of 2 allowed for the direct modification of this cyclic dinucleotide at the 8 position, providing the unsubstituted parent N1-cIDPR (4) as well as the 8-phenyl (5), 8-azido (6), and 8-amino (7) N1-cIDPR analogues. In Jurkat T-lymphocytes, N1-cIDPR 4 induced Ca2+ release with an almost identical profile as the natural agonist cADPR, illustrating the value of this approach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932322     DOI: 10.1021/jo050085s

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  18 in total

1.  Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.

Authors:  T Kirchberger; G Wagner; J Xu; C Cordiglieri; P Wang; A Gasser; R Fliegert; S Bruhn; A Flügel; F E Lund; L-H Zhang; B V L Potter; A H Guse
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

2.  Design, Synthesis, and Chemical and Biological Properties of Cyclic ADP-4-Thioribose as a Stable Equivalent of Cyclic ADP-Ribose.

Authors:  Takayoshi Tsuzuki; Satoshi Takano; Natsumi Sakaguchi; Takashi Kudoh; Takashi Murayama; Takashi Sakurai; Minako Hashii; Haruhiro Higashida; Karin Weber; Andreas H Guse; Tomoshi Kameda; Takatsugu Hirokawa; Yasuhiro Kumaki; Mitsuhiro Arisawa; Barry V L Potter; Satoshi Shuto
Journal:  Messenger (Los Angel)       Date:  2014-06-01

3.  Synthesis of cyclic adenosine 5'-diphosphate ribose analogues: a C2'endo/syn "southern" ribose conformation underlies activity at the sea urchin cADPR receptor.

Authors:  Christelle Moreau; Gloria A Ashamu; Victoria C Bailey; Antony Galione; Andreas H Guse; Barry V L Potter
Journal:  Org Biomol Chem       Date:  2010-10-25       Impact factor: 3.876

4.  Aberrant cyclization affords a C-6 modified cyclic adenosine 5'-diphosphoribose analogue with biological activity in Jurkat T cells.

Authors:  Christelle Moreau; Tanja Kirchberger; Bo Zhang; Mark P Thomas; Karin Weber; Andreas H Guse; Barry V L Potter
Journal:  J Med Chem       Date:  2012-02-08       Impact factor: 7.446

5.  Total synthesis of a cyclic adenosine 5'-diphosphate ribose receptor agonist.

Authors:  Joanna M Swarbrick; Barry V L Potter
Journal:  J Org Chem       Date:  2012-01-31       Impact factor: 4.354

6.  'Click cyclic ADP-ribose': a neutral second messenger mimic.

Authors:  Joanna M Swarbrick; Richard Graeff; Clive Garnham; Mark P Thomas; Antony Galione; Barry V L Potter
Journal:  Chem Commun (Camb)       Date:  2014-01-23       Impact factor: 6.222

7.  Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.

Authors:  Qun Liu; Richard Graeff; Irina A Kriksunov; Hong Jiang; Bo Zhang; Norman Oppenheimer; Hening Lin; Barry V L Potter; Hon Cheung Lee; Quan Hao
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

8.  CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.

Authors:  Christelle Moreau; Qun Liu; Richard Graeff; Gerd K Wagner; Mark P Thomas; Joanna M Swarbrick; Satoshi Shuto; Hon Cheung Lee; Quan Hao; Barry V L Potter
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists.

Authors:  Christelle Moreau; Tanja Kirchberger; Joanna M Swarbrick; Stephen J Bartlett; Ralf Fliegert; Timur Yorgan; Andreas Bauche; Angelika Harneit; Andreas H Guse; Barry V L Potter
Journal:  J Med Chem       Date:  2013-12-13       Impact factor: 7.446

10.  Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.

Authors:  Joanna M Swarbrick; Richard Graeff; Hongmin Zhang; Mark P Thomas; Quan Hao; Barry V L Potter
Journal:  J Med Chem       Date:  2014-10-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.